异基因造血干细胞移植后由非烟曲霉引起的侵袭性曲霉病

V. Markelov, Y. Rogacheva, M. Popova, A. G. Volkova, I. Nikolaev, O. Pinegina, A. A. Spididonova, S. Ignatieva, T. Bogomolova, O. Goloshchapov, Y. Vlasova, E. Morozova, M. D. Vladovskaya, S. Bondarenko, N. Klimko, A. Kulagin
{"title":"异基因造血干细胞移植后由非烟曲霉引起的侵袭性曲霉病","authors":"V. Markelov, Y. Rogacheva, M. Popova, A. G. Volkova, I. Nikolaev, O. Pinegina, A. A. Spididonova, S. Ignatieva, T. Bogomolova, O. Goloshchapov, Y. Vlasova, E. Morozova, M. D. Vladovskaya, S. Bondarenko, N. Klimko, A. Kulagin","doi":"10.22625/2072-6732-2022-14-5-5-13","DOIUrl":null,"url":null,"abstract":"   Objective. To study the features of invasive aspergillosis (IA) due to A. non-fumigatus versus A. fumigatus in adult (≥ 18 years) recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in 2016-2021.   Materials and methods. The study included 33 patients with IA caused by A. non-fumigatus (n = 20) and A. fumigatus (n = 13). A comparative analysis of cases of IA, the results of therapy and outcomes in patients after allo-HSCT in the RM Gorbacheva Research Institute was performed. Diagnostic criteria EORTC / MSGERC 2020 were used.   Results. Invasive aspergillosis caused by A. non-fumigatus made up the majority (60.6 %) of IA cases with an identified pathogen registered in patients after allo-HSCT in the period from 2016 to 2021. The main etiological agents in the A. non-fumigatus group were A. niger in 13 (65 %) patients, A. flavus – in 4 (20 %). The median day of diagnosis of A. non-fumigatus IAwas + 110 days (17–2093), for A. fumigatus it was + 46 days (2–866) (p = 0.171). Overall 12-week survival was 55 % and 59.2 % in the A. non-fumigatus and A. fumigatus groups, respectively (p = 0.617). The majority of patients in both the A. fumigatus (n = 10, 77 %) and A. non-fumigatus (n = 16, 80 %) groups received voriconazole as initial antifungal therapy. Second-linetherapy was required in 2 (10 %) patients with A. non-fumigatus IA: liposomal amphotericin B and echinocandins with or with-out posaconazole, and 2 (15 %) patients in the A. fumigatus group: liposomal amphotericin B and voriconazole in combination with echinocandins. A comparative analysis showed that in patients from the two groups, none of the assessed signs (gender, age, underlying disease, disease status at the time of transplantation, time from diagnosis to allo-HSCT, source of hematopoietic stem cells, conditioning regimen, donor type, antifungal prophylaxis, cytomegalovirus reactivation, severe acute and chronic graft-versus-host disease) did not differ significantly.   Conclusions. A. niger is the main causative agent of IA caused by A. non-fumigatus. Patients characteristics, their treatment and outcomes did not differ significantly between the A. non-fumigatus and A. fumigatus groups.","PeriodicalId":226950,"journal":{"name":"Journal Infectology","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Invasive aspergillosis caused by Aspergillus non-fumigatus after allogeneic hematopoietic stem cell transplantation\",\"authors\":\"V. Markelov, Y. Rogacheva, M. Popova, A. G. Volkova, I. Nikolaev, O. Pinegina, A. A. Spididonova, S. Ignatieva, T. Bogomolova, O. Goloshchapov, Y. Vlasova, E. Morozova, M. D. Vladovskaya, S. Bondarenko, N. Klimko, A. Kulagin\",\"doi\":\"10.22625/2072-6732-2022-14-5-5-13\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"   Objective. To study the features of invasive aspergillosis (IA) due to A. non-fumigatus versus A. fumigatus in adult (≥ 18 years) recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in 2016-2021.   Materials and methods. The study included 33 patients with IA caused by A. non-fumigatus (n = 20) and A. fumigatus (n = 13). A comparative analysis of cases of IA, the results of therapy and outcomes in patients after allo-HSCT in the RM Gorbacheva Research Institute was performed. Diagnostic criteria EORTC / MSGERC 2020 were used.   Results. Invasive aspergillosis caused by A. non-fumigatus made up the majority (60.6 %) of IA cases with an identified pathogen registered in patients after allo-HSCT in the period from 2016 to 2021. The main etiological agents in the A. non-fumigatus group were A. niger in 13 (65 %) patients, A. flavus – in 4 (20 %). The median day of diagnosis of A. non-fumigatus IAwas + 110 days (17–2093), for A. fumigatus it was + 46 days (2–866) (p = 0.171). Overall 12-week survival was 55 % and 59.2 % in the A. non-fumigatus and A. fumigatus groups, respectively (p = 0.617). The majority of patients in both the A. fumigatus (n = 10, 77 %) and A. non-fumigatus (n = 16, 80 %) groups received voriconazole as initial antifungal therapy. Second-linetherapy was required in 2 (10 %) patients with A. non-fumigatus IA: liposomal amphotericin B and echinocandins with or with-out posaconazole, and 2 (15 %) patients in the A. fumigatus group: liposomal amphotericin B and voriconazole in combination with echinocandins. A comparative analysis showed that in patients from the two groups, none of the assessed signs (gender, age, underlying disease, disease status at the time of transplantation, time from diagnosis to allo-HSCT, source of hematopoietic stem cells, conditioning regimen, donor type, antifungal prophylaxis, cytomegalovirus reactivation, severe acute and chronic graft-versus-host disease) did not differ significantly.   Conclusions. A. niger is the main causative agent of IA caused by A. non-fumigatus. Patients characteristics, their treatment and outcomes did not differ significantly between the A. non-fumigatus and A. fumigatus groups.\",\"PeriodicalId\":226950,\"journal\":{\"name\":\"Journal Infectology\",\"volume\":\"25 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal Infectology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22625/2072-6732-2022-14-5-5-13\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal Infectology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22625/2072-6732-2022-14-5-5-13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目标。研究2016-2021年同种异体造血干细胞移植(alloc - hsct)成人(≥18岁)受者非烟曲霉与烟曲霉所致侵袭性曲霉病(IA)的特征。材料和方法。本研究纳入33例由非烟曲霉属和烟曲霉属引起的IA患者(n = 20)和烟曲霉属(n = 13)。我们对戈尔巴乔夫研究所同种异体造血干细胞移植患者的IA病例、治疗结果和预后进行了比较分析。诊断标准为EORTC / MSGERC 2020。结果。2016年至2021年,在同种异体造血干细胞移植后登记的IA病例中,由非烟曲霉引起的侵袭性曲霉病占大多数(60.6%)。非烟曲霉组主要病原为黑曲霉13例(65%),黄曲霉4例(20%)。非烟曲霉诊断的中位天数为+ 110 d(17-2093),烟曲霉诊断的中位天数为+ 46 d (2-866) (p = 0.171)。非烟螨组和烟螨组12周总存活率分别为55%和59.2% (p = 0.617)。烟曲霉感染组(n = 10, 77%)和非烟曲霉感染组(n = 16, 80%)的大多数患者均以伏立康唑作为初始抗真菌治疗。2例(10%)非烟曲霉IA患者需要二线治疗:脂质体两性霉素B和棘白菌素联合泊沙康唑或不联合棘白菌素;烟曲霉组2例(15%)患者:脂质体两性霉素B和voriconazole联合棘白菌素。一项比较分析显示,两组患者的评估指标(性别、年龄、基础疾病、移植时的疾病状态、从诊断到异体造血干细胞移植的时间、造血干细胞来源、调节方案、供体类型、抗真菌预防、巨细胞病毒再激活、严重急性和慢性移植物抗宿主病)均无显著差异。结论。黑曲霉是非烟曲霉引起的内毒素的主要病原体。患者的特征、治疗和结果在非烟曲霉组和烟曲霉组之间没有显著差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Invasive aspergillosis caused by Aspergillus non-fumigatus after allogeneic hematopoietic stem cell transplantation
   Objective. To study the features of invasive aspergillosis (IA) due to A. non-fumigatus versus A. fumigatus in adult (≥ 18 years) recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in 2016-2021.   Materials and methods. The study included 33 patients with IA caused by A. non-fumigatus (n = 20) and A. fumigatus (n = 13). A comparative analysis of cases of IA, the results of therapy and outcomes in patients after allo-HSCT in the RM Gorbacheva Research Institute was performed. Diagnostic criteria EORTC / MSGERC 2020 were used.   Results. Invasive aspergillosis caused by A. non-fumigatus made up the majority (60.6 %) of IA cases with an identified pathogen registered in patients after allo-HSCT in the period from 2016 to 2021. The main etiological agents in the A. non-fumigatus group were A. niger in 13 (65 %) patients, A. flavus – in 4 (20 %). The median day of diagnosis of A. non-fumigatus IAwas + 110 days (17–2093), for A. fumigatus it was + 46 days (2–866) (p = 0.171). Overall 12-week survival was 55 % and 59.2 % in the A. non-fumigatus and A. fumigatus groups, respectively (p = 0.617). The majority of patients in both the A. fumigatus (n = 10, 77 %) and A. non-fumigatus (n = 16, 80 %) groups received voriconazole as initial antifungal therapy. Second-linetherapy was required in 2 (10 %) patients with A. non-fumigatus IA: liposomal amphotericin B and echinocandins with or with-out posaconazole, and 2 (15 %) patients in the A. fumigatus group: liposomal amphotericin B and voriconazole in combination with echinocandins. A comparative analysis showed that in patients from the two groups, none of the assessed signs (gender, age, underlying disease, disease status at the time of transplantation, time from diagnosis to allo-HSCT, source of hematopoietic stem cells, conditioning regimen, donor type, antifungal prophylaxis, cytomegalovirus reactivation, severe acute and chronic graft-versus-host disease) did not differ significantly.   Conclusions. A. niger is the main causative agent of IA caused by A. non-fumigatus. Patients characteristics, their treatment and outcomes did not differ significantly between the A. non-fumigatus and A. fumigatus groups.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信